JP2011517320A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011517320A5 JP2011517320A5 JP2010549831A JP2010549831A JP2011517320A5 JP 2011517320 A5 JP2011517320 A5 JP 2011517320A5 JP 2010549831 A JP2010549831 A JP 2010549831A JP 2010549831 A JP2010549831 A JP 2010549831A JP 2011517320 A5 JP2011517320 A5 JP 2011517320A5
- Authority
- JP
- Japan
- Prior art keywords
- mmp
- binding protein
- human
- binding
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3306808P | 2008-03-03 | 2008-03-03 | |
| US61/033,068 | 2008-03-03 | ||
| PCT/US2009/035926 WO2009111508A2 (en) | 2008-03-03 | 2009-03-03 | Metalloproteinase 9 and metalloproteinase 2 binding proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011517320A JP2011517320A (ja) | 2011-06-02 |
| JP2011517320A5 true JP2011517320A5 (https=) | 2012-04-26 |
Family
ID=41056616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010549831A Pending JP2011517320A (ja) | 2008-03-03 | 2009-03-03 | メタロプロテアーゼ９結合タンパク質およびメタロプロテアーゼ２結合タンパク質 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US8013125B2 (https=) |
| EP (1) | EP2262840A4 (https=) |
| JP (1) | JP2011517320A (https=) |
| AU (1) | AU2009221916A1 (https=) |
| CA (1) | CA2717803A1 (https=) |
| WO (1) | WO2009111508A2 (https=) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2635588C (en) | 2005-12-30 | 2015-11-10 | Dyax Corp. | Metalloproteinase binding proteins |
| AU2008338421A1 (en) | 2007-12-17 | 2009-06-25 | Dyax Corp. | Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins |
| WO2009079581A1 (en) * | 2007-12-17 | 2009-06-25 | Dyax Corp. | Evaluating mmp expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer |
| AU2009221916A1 (en) | 2008-03-03 | 2009-09-11 | Dyax Corp. | Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| WO2009111450A2 (en) * | 2008-03-03 | 2009-09-11 | Dyax Corp. | Metalloproteinase 9 binding proteins |
| WO2011028883A2 (en) * | 2009-09-03 | 2011-03-10 | Dyax Corp. | Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| US8530453B2 (en) * | 2009-09-28 | 2013-09-10 | Aquilus Pharmaceuticals, Inc. | Compounds and methods for the treatment of pain and other diseases |
| US8697078B2 (en) * | 2010-01-27 | 2014-04-15 | Yeda Research And Development Co. Ltd. | Antibodies that inhibit metalloproteins |
| NZ604464A (en) | 2010-06-14 | 2014-03-28 | Vaccinex Inc | Anti-vegf antibodies and uses thereof |
| KR101900435B1 (ko) | 2010-06-16 | 2018-09-20 | 트렐리스 바이오싸이언스 인코포레이티드 | 인간 사이토메갈로바이러스 gB 단백질에 대한 고친화도 인간 항체 |
| KR101930179B1 (ko) * | 2010-08-27 | 2018-12-17 | 길리아드 바이오로직스, 인크. | 매트릭스 메탈로프로테이나제 ９에 대한 항체 |
| AU2011318567B2 (en) * | 2010-10-19 | 2017-02-09 | Mayo Foundation For Medical Education And Research | Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological disease |
| US20140199324A1 (en) * | 2011-03-24 | 2014-07-17 | Daniel T. Dransfield | Evaluating protein expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer |
| US10314909B2 (en) | 2011-10-21 | 2019-06-11 | Dyax Corp. | Combination therapy comprising an MMP-14 binding protein |
| NZ629178A (en) | 2012-02-29 | 2016-09-30 | Gilead Biologics Inc | Antibodies to matrix metalloproteinase 9 |
| AU2012318302C1 (en) | 2012-02-29 | 2017-06-15 | Gilead Biologics, Inc. | Antibodies to matrix metalloproteinase 9 |
| US9732154B2 (en) | 2014-02-28 | 2017-08-15 | Janssen Biotech, Inc. | Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia |
| US9603927B2 (en) | 2014-02-28 | 2017-03-28 | Janssen Biotech, Inc. | Combination therapies with anti-CD38 antibodies |
| EP2985295A1 (en) | 2014-08-13 | 2016-02-17 | Calypso Biotech SA | Antibodies specific for MMP9 |
| EP2985296A1 (en) | 2014-08-13 | 2016-02-17 | Calypso Biotech SA | Antibodies specific for MMP9 |
| MX386886B (es) | 2014-09-09 | 2025-03-12 | Janssen Biotech Inc | Combinación de anticuerpos anti-cd38 y ácido todo-trans retinoico para usarse en terapias. |
| AU2015358615B2 (en) | 2014-12-04 | 2021-08-05 | Janssen Biotech, Inc. | Anti-CD38 antibodies for treatment of acute myeloid leukemia |
| MX389805B (es) | 2015-05-20 | 2025-03-11 | Janssen Biotech Inc | Anticuerpos anti-cd38 para el tratamiento de amiloidosis de cadena ligera y otras enfermedades malignas hematológicas positivas para cd38. |
| AU2016282674B2 (en) | 2015-06-22 | 2022-01-13 | Janssen Biotech, Inc. | Combination therapies for heme malignancies with anti-CD38 antibodies and survivin inhibitors |
| US20170044265A1 (en) | 2015-06-24 | 2017-02-16 | Janssen Biotech, Inc. | Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38 |
| DK3827845T3 (da) | 2015-11-03 | 2022-05-23 | Janssen Biotech Inc | Subkutane formuleringer af anti-cd38-antistoffer og anvendelser deraf |
| US10781261B2 (en) | 2015-11-03 | 2020-09-22 | Janssen Biotech, Inc. | Subcutaneous formulations of anti-CD38 antibodies and their uses |
| US20200306283A1 (en) | 2016-06-22 | 2020-10-01 | William Warren HARLESS | Cancer treatment and metastasis inhibition using an anti-cancer stem cell agent in combination with a neu1 sialidase inhibitor or a cytokine inhibitor after primary cancer treatment |
| JP2019527678A (ja) | 2016-06-28 | 2019-10-03 | ユーエムセー・ユトレヒト・ホールディング・ベー・フェー | ＣＤ３８に特異的に結合する抗体によるＩｇＥ媒介疾患の治療 |
| CN108456250B (zh) * | 2017-02-17 | 2025-11-28 | 恺兴生命科技(上海)有限公司 | 靶向il-13ra2的抗体及其应用 |
| WO2018169785A2 (en) * | 2017-03-13 | 2018-09-20 | The Government Of The United States Of America As Represented By The Secretary Of The Army | Therapeutic antibodies to marburg virus |
| JP2021502961A (ja) | 2017-10-31 | 2021-02-04 | ヤンセン バイオテツク，インコーポレーテツド | 高リスク多発性骨髄腫の治療方法 |
| EP3724657A4 (en) * | 2017-12-15 | 2021-12-29 | Bomi, Llc | Anti-cannabidiol antibody and uses thereof |
| CN110642948B (zh) * | 2019-10-09 | 2021-06-29 | 达石药业(广东)有限公司 | B7-h3纳米抗体、其制备方法及用途 |
| PE20260306A1 (es) | 2023-06-12 | 2026-02-11 | Amgen Inc | Proteinas de union a receptor de linfotoxina beta agonistas |
| WO2025076280A1 (en) | 2023-10-05 | 2025-04-10 | Ashibio, Inc. | Methods and compositions for treating mmp-9 mediated disorders |
| WO2026076260A1 (en) | 2024-10-03 | 2026-04-09 | Ashibio, Inc. | Methods and compositions for mmp-9 inhibition for use with non-genetic heterotopic ossification disorders |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9809764D0 (en) | 1998-05-07 | 1998-07-08 | Isis Innovation | MMP-9 Gene polymorphisms |
| CN1379685A (zh) | 1999-07-13 | 2002-11-13 | 南加利福尼亚大学 | 用基于MMP－9和β1整联蛋白的拮抗剂抑制血管发生的新方法和组合物 |
| WO2001026671A1 (en) * | 1999-10-12 | 2001-04-19 | Smithkline Beecham Corporation | Methods of treatment using dual matrix-metalloproteinase-2 and matrix metalloproteinase-9 inhibitors |
| US6573096B1 (en) | 2000-04-01 | 2003-06-03 | The Research Foundation At State University Of New York | Compositions and methods for inhibition of cancer invasion and angiogenesis |
| EP1297112A2 (en) * | 2000-05-22 | 2003-04-02 | PHARMACIA & UPJOHN COMPANY | Novel matrix metalloproteinases |
| AR028606A1 (es) * | 2000-05-24 | 2003-05-14 | Smithkline Beecham Corp | Nuevos inhibidores de mmp-2/mmp-9 |
| KR100919593B1 (ko) * | 2000-06-29 | 2009-09-29 | 아보트 러보러터리즈 | 이중 특이성 항체 및 이의 제조 방법 및 이를 포함하는 조성물 |
| US20070258987A1 (en) | 2000-11-28 | 2007-11-08 | Seattle Genetics, Inc. | Recombinant Anti-Cd30 Antibodies and Uses Thereof |
| AU2002235692A1 (en) * | 2001-02-23 | 2002-09-04 | Biophage Inc. | Methods and compositions for preventing and treating neutrophil-mediated diseases |
| ATE458199T1 (de) | 2001-05-04 | 2010-03-15 | Biosite Inc | Diagnostische marker der akuten koronaren syndrome und ihre verwendungen |
| AU2003274059A1 (en) * | 2002-10-23 | 2004-05-13 | F. Hoffmann-La Roche Ag | Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof |
| ES2433440T3 (es) * | 2003-04-04 | 2013-12-11 | Yeda Research And Development Co. Ltd. | Anticuerpos contra MMP2 o MMP9 y composiciones farmacéuticas que contienen los mismos útiles para inhibir la actividad de dichas metaloproteínas |
| US7435800B2 (en) | 2003-05-23 | 2008-10-14 | Chi-Mei Medical Center | Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation |
| US20050118632A1 (en) * | 2003-11-06 | 2005-06-02 | Jian Chen | Polynucleotides and polypeptides encoding a novel metalloprotease, Protease-40b |
| CN100497324C (zh) * | 2004-05-27 | 2009-06-10 | 武汉科艾硒医药科技发展有限公司 | 具有抗纤维化及抑制明胶酶活性的化合物及其应用 |
| WO2006036928A2 (en) | 2004-09-27 | 2006-04-06 | Wayne State University | Inhibitors of matrix metalloproteinases to treat neurological disorders |
| US20080254490A1 (en) | 2005-02-02 | 2008-10-16 | Ramkumar Menon | Salivary Protease Assays for Identifying Increased Risk of Preterm Delivery Induced by Premature Rupture of Fetal Membranes |
| DE102005015040A1 (de) | 2005-03-31 | 2006-10-05 | Sanofi-Aventis Deutschland Gmbh | Substituierte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
| EP1931632A4 (en) | 2005-08-18 | 2011-05-11 | Microbia Inc | USEFUL INDOOR CONNECTIONS |
| US8092819B2 (en) * | 2006-01-27 | 2012-01-10 | Cook Medical Technologies LLC. | Implantable medical device coated with a bioactive agent |
| WO2007149948A2 (en) | 2006-06-20 | 2007-12-27 | The Gov. Of The Usa As Represented By The Secretary Of The Department Of Health And Human Services | Compositions and methods for diagnosis and treatment of tumors |
| KR20090113908A (ko) * | 2007-02-23 | 2009-11-02 | 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 | 금속단백질 활성 억제용 항체 및 이를 함유하는 약학적 조성물 |
| WO2009079581A1 (en) | 2007-12-17 | 2009-06-25 | Dyax Corp. | Evaluating mmp expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer |
| AU2008338421A1 (en) | 2007-12-17 | 2009-06-25 | Dyax Corp. | Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins |
| AU2009221916A1 (en) | 2008-03-03 | 2009-09-11 | Dyax Corp. | Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| WO2009111450A2 (en) | 2008-03-03 | 2009-09-11 | Dyax Corp. | Metalloproteinase 9 binding proteins |
| WO2010045388A2 (en) | 2008-10-14 | 2010-04-22 | Dyax Corp. | Use of mmp-9 and mmp-12 binding proteins for the treatment and prevention of systemic sclerosis |
| EP2350305A4 (en) | 2008-10-22 | 2013-03-06 | Dyax Corp | COMBINATION TREATMENTS WITH PROTEASE BINDING PROTEINS FOR INFLAMMATORY DISEASES |
| WO2011028883A2 (en) | 2009-09-03 | 2011-03-10 | Dyax Corp. | Metalloproteinase 9 and metalloproteinase 2 binding proteins |
-
2009
- 2009-03-03 AU AU2009221916A patent/AU2009221916A1/en not_active Abandoned
- 2009-03-03 CA CA2717803A patent/CA2717803A1/en not_active Abandoned
- 2009-03-03 US US12/397,285 patent/US8013125B2/en active Active
- 2009-03-03 WO PCT/US2009/035926 patent/WO2009111508A2/en not_active Ceased
- 2009-03-03 EP EP09717527A patent/EP2262840A4/en not_active Withdrawn
- 2009-03-03 JP JP2010549831A patent/JP2011517320A/ja active Pending
-
2011
- 2011-08-01 US US13/195,710 patent/US20110300157A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8013125B2 (en) | Metalloproteinase 9 and metalloproteinase 2 binding proteins | |
| US8008445B2 (en) | Metalloproteinase 9 binding proteins | |
| JP2011517320A5 (https=) | ||
| JP2011517662A5 (https=) | ||
| US8114968B2 (en) | Metalloproteinase-12 specific monoclonal antibody | |
| US20110135573A1 (en) | Metalloproteinase 9 and metalloproteinase 2 binding proteins | |
| JP6660294B2 (ja) | 活性化可能抗体を結合するための組成物及び方法 | |
| JP6333882B2 (ja) | 抗体−薬剤コンジュゲート | |
| JP2023159314A (ja) | マトリプターゼ及びｕ‐プラスミノーゲン活性化因子の基質及び他の切断可能部分、並びにその使用方法 | |
| DK2521568T3 (en) | PLASMACALLIC CLEANING PROTEINS | |
| US20220267455A1 (en) | Anti-il1rap antibodies and antibody drug conjugates | |
| CN113271956A (zh) | 基质金属蛋白酶可裂解的和丝氨酸或半胱氨酸蛋白酶可裂解的底物及其使用方法 | |
| CA2635588C (en) | Metalloproteinase binding proteins | |
| AU2018300237A1 (en) | Anti-CD166 antibodies and uses thereof | |
| WO2009097397A2 (en) | Metalloproteinase binding proteins | |
| CN110078827A (zh) | 结合表皮生长因子受体的可活化的抗体其使用方法 | |
| JP2016538240A (ja) | マトリックスメタロプロテイナーゼ基質及び他の切断可能部分並びにそれらの使用方法 | |
| WO2010045388A2 (en) | Use of mmp-9 and mmp-12 binding proteins for the treatment and prevention of systemic sclerosis | |
| AU2019204295A1 (en) | Plasma kallikrein binding proteins |